Abstract
Summary
LPI (LP Information)' newest research report, the “Cell Line Development Services Industry Forecast” looks at past sales and reviews total world Cell Line Development Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Line Development Services sales for 2023 through 2029. With Cell Line Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line Development Services industry.
This Insight Report provides a comprehensive analysis of the global Cell Line Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Line Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Development Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Development Services.
The global Cell Line Development Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Line Development Services players cover Lonza, MabPlex, Thermo Fisher, Solentim, Sigma-Aldrich, Selexis, Corning and Sartorius Stedim Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Development Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Biotechnology
Instruments and Reagents
Segmentation by application
Bioproduction
Recombinant Protein Therapeutics
Tissue Engineering & Regenerative Medicines
Drug Discovery
Toxicity Testing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
MabPlex
Thermo Fisher
Solentim
Sigma-Aldrich
Selexis
Corning
Sartorius Stedim Biotech
This Insight Report provides a comprehensive analysis of the global Cell Line Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Line Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Development Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Development Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Development Services.
The global Cell Line Development Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Line Development Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Line Development Services players cover Lonza, MabPlex, Thermo Fisher, Solentim, Sigma-Aldrich, Selexis, Corning and Sartorius Stedim Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Development Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Biotechnology
Instruments and Reagents
Segmentation by application
Bioproduction
Recombinant Protein Therapeutics
Tissue Engineering & Regenerative Medicines
Drug Discovery
Toxicity Testing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
MabPlex
Thermo Fisher
Solentim
Sigma-Aldrich
Selexis
Corning
Sartorius Stedim Biotech
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Line Development Services Market Size 2018-2029
2.1.2 Cell Line Development Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell Line Development Services Segment by Type
2.2.1 Biotechnology
2.2.2 Instruments and Reagents
2.3 Cell Line Development Services Market Size by Type
2.3.1 Cell Line Development Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell Line Development Services Market Size Market Share by Type (2018-2023)
2.4 Cell Line Development Services Segment by Application
2.4.1 Bioproduction
2.4.2 Recombinant Protein Therapeutics
2.4.3 Tissue Engineering & Regenerative Medicines
2.4.4 Drug Discovery
2.4.5 Toxicity Testing
2.5 Cell Line Development Services Market Size by Application
2.5.1 Cell Line Development Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell Line Development Services Market Size Market Share by Application (2018-2023)
3 Cell Line Development Services Market Size by Player
3.1 Cell Line Development Services Market Size Market Share by Players
3.1.1 Global Cell Line Development Services Revenue by Players (2018-2023)
3.1.2 Global Cell Line Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell Line Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Line Development Services by Regions
4.1 Cell Line Development Services Market Size by Regions (2018-2023)
4.2 Americas Cell Line Development Services Market Size Growth (2018-2023)
4.3 APAC Cell Line Development Services Market Size Growth (2018-2023)
4.4 Europe Cell Line Development Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell Line Development Services Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cell Line Development Services Market Size by Country (2018-2023)
5.2 Americas Cell Line Development Services Market Size by Type (2018-2023)
5.3 Americas Cell Line Development Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Line Development Services Market Size by Region (2018-2023)
6.2 APAC Cell Line Development Services Market Size by Type (2018-2023)
6.3 APAC Cell Line Development Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Line Development Services by Country (2018-2023)
7.2 Europe Cell Line Development Services Market Size by Type (2018-2023)
7.3 Europe Cell Line Development Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Line Development Services by Region (2018-2023)
8.2 Middle East & Africa Cell Line Development Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell Line Development Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell Line Development Services Market Forecast
10.1 Global Cell Line Development Services Forecast by Regions (2024-2029)
10.1.1 Global Cell Line Development Services Forecast by Regions (2024-2029)
10.1.2 Americas Cell Line Development Services Forecast
10.1.3 APAC Cell Line Development Services Forecast
10.1.4 Europe Cell Line Development Services Forecast
10.1.5 Middle East & Africa Cell Line Development Services Forecast
10.2 Americas Cell Line Development Services Forecast by Country (2024-2029)
10.2.1 United States Cell Line Development Services Market Forecast
10.2.2 Canada Cell Line Development Services Market Forecast
10.2.3 Mexico Cell Line Development Services Market Forecast
10.2.4 Brazil Cell Line Development Services Market Forecast
10.3 APAC Cell Line Development Services Forecast by Region (2024-2029)
10.3.1 China Cell Line Development Services Market Forecast
10.3.2 Japan Cell Line Development Services Market Forecast
10.3.3 Korea Cell Line Development Services Market Forecast
10.3.4 Southeast Asia Cell Line Development Services Market Forecast
10.3.5 India Cell Line Development Services Market Forecast
10.3.6 Australia Cell Line Development Services Market Forecast
10.4 Europe Cell Line Development Services Forecast by Country (2024-2029)
10.4.1 Germany Cell Line Development Services Market Forecast
10.4.2 France Cell Line Development Services Market Forecast
10.4.3 UK Cell Line Development Services Market Forecast
10.4.4 Italy Cell Line Development Services Market Forecast
10.4.5 Russia Cell Line Development Services Market Forecast
10.5 Middle East & Africa Cell Line Development Services Forecast by Region (2024-2029)
10.5.1 Egypt Cell Line Development Services Market Forecast
10.5.2 South Africa Cell Line Development Services Market Forecast
10.5.3 Israel Cell Line Development Services Market Forecast
10.5.4 Turkey Cell Line Development Services Market Forecast
10.5.5 GCC Countries Cell Line Development Services Market Forecast
10.6 Global Cell Line Development Services Forecast by Type (2024-2029)
10.7 Global Cell Line Development Services Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell Line Development Services Product Offered
11.1.3 Lonza Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 MabPlex
11.2.1 MabPlex Company Information
11.2.2 MabPlex Cell Line Development Services Product Offered
11.2.3 MabPlex Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 MabPlex Main Business Overview
11.2.5 MabPlex Latest Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Information
11.3.2 Thermo Fisher Cell Line Development Services Product Offered
11.3.3 Thermo Fisher Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Main Business Overview
11.3.5 Thermo Fisher Latest Developments
11.4 Solentim
11.4.1 Solentim Company Information
11.4.2 Solentim Cell Line Development Services Product Offered
11.4.3 Solentim Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Solentim Main Business Overview
11.4.5 Solentim Latest Developments
11.5 Sigma-Aldrich
11.5.1 Sigma-Aldrich Company Information
11.5.2 Sigma-Aldrich Cell Line Development Services Product Offered
11.5.3 Sigma-Aldrich Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sigma-Aldrich Main Business Overview
11.5.5 Sigma-Aldrich Latest Developments
11.6 Selexis
11.6.1 Selexis Company Information
11.6.2 Selexis Cell Line Development Services Product Offered
11.6.3 Selexis Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Selexis Main Business Overview
11.6.5 Selexis Latest Developments
11.7 Corning
11.7.1 Corning Company Information
11.7.2 Corning Cell Line Development Services Product Offered
11.7.3 Corning Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Corning Main Business Overview
11.7.5 Corning Latest Developments
11.8 Sartorius Stedim Biotech
11.8.1 Sartorius Stedim Biotech Company Information
11.8.2 Sartorius Stedim Biotech Cell Line Development Services Product Offered
11.8.3 Sartorius Stedim Biotech Cell Line Development Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sartorius Stedim Biotech Main Business Overview
11.8.5 Sartorius Stedim Biotech Latest Developments
12 Research Findings and Conclusion